🇺🇸 FDA
Pipeline program

Cx601

Cx601-0302

Phase 3 other completed

Quick answer

Cx601 for Crohn's Disease is a Phase 3 program (other) at TAKEDA PHARMACEUTICAL CO LTD with 3 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Crohn's Disease
Phase
Phase 3
Modality
other
Status
completed

Clinical trials